SP 39 (Guaifenesin 400 mg)
Pill imprint SP 39 has been identified as Guaifenesin 400 mg.
Guaifenesin is used in the treatment of bronchitis; fibromyalgia; cough; bronchiectasis and belongs to the drug class expectorants. Risk cannot be ruled out during pregnancy. Guaifenesin 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
Guaifenesin
- Imprint:
- SP 39
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Expectorants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Reese Pharmaceutical Co.
More about guaifenesin
Consumer resources
- Guaifenesin
- Guaifenesin granules
- Guaifenesin immediate-release capsules
- Guaifenesin liquid
- Guaifenesin sustained-release tablets
- Guaifenesin (Advanced Reading)
- Other brands: Mucinex, Robitussin Chest Congestion, Guiatuss, GG 200 NR, More (19) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
